Gene-engineered mouse models further confirm that Sox2 is essential for neuroendocrine differentiation in phosphatase and tensin homolog (Pten)-deficient prostate adenocarcinomas induced by treatment. Here, PTEN is linked to prostate adenocarcinoma.